Search Results - "Beutner, Karl R"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    American Academy of Dermatology evidence-based guideline development process: Responding to new challenges and establishing transparency by Smith Begolka, Wendy, MS, Elston, Dirk M., MD, Beutner, Karl R., MD, PhD

    “…Background Evidence-based clinical guidelines are developed to educate and inform physicians about best practices in patient care, and assist providers in the…”
    Get full text
    Journal Article
  5. 5

    Recent progress on the topical therapy of onychomycosis by Alley, Michael R K, Baker, Stephen J, Beutner, Karl R, Plattner, Jacob

    Published in Expert opinion on investigational drugs (01-02-2007)
    “…Onychomycosis is a fungal infection of the fingernails and toenails that results in thickening, discoloration, splitting of the nails and lifting of the nail…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts by BEUTNER, K. R, TYRING, S. K, TROFATTER, K. F, DOUGLAS, J. M, SPRUANCE, S, OWENS, M. L, FOX, T. L, HOUGHAM, A. J, SCHMITT, K. A

    Published in Antimicrobial Agents and Chemotherapy (01-04-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Sinecatechins, a Defined Green Tea Extract, in the Treatment of External Anogenital Warts : A Randomized Controlled Trial by TATTI, Silvio, SWINEHART, James M, THIELERT, Claus, TAWFIK, Hoda, MESCHEDER, Axel, BEUTNER, Karl R

    Published in Obstetrics and gynecology (New York. 1953) (01-06-2008)
    “…To estimate the clinical efficacy of topical sinecatechins, a defined green tea extract, in the treatment of external genital and perianal warts. This was a…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest by Pappas, D J, Lizee, A, Paunic, V, Beutner, K R, Motyer, A, Vukcevic, D, Leslie, S, Biesiada, J, Meller, J, Taylor, K D, Zheng, X, Zhao, L P, Gourraud, P-A, Hollenbach, J A, Mack, S J, Maiers, M

    Published in The pharmacogenomics journal (22-05-2018)
    “…Four single nucleotide polymorphism (SNP)-based human leukocyte antigen (HLA) imputation methods (e-HLA, HIBAG, HLA*IMP:02 and MAGPrediction) were trained…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream by Beutner, Karl R., Geisse, John K., Helman, Donita, Fox, Terry L., Ginkel d, Angela, Owens, Mary L.

    “…Background: Basal cell carcinoma (BCC) responds to interferon therapy. Imiquimod is a cytokine and interferon inducer. Objective: This randomized, double-blind…”
    Get full text
    Journal Article